Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.538 +0.278 (+3.00%)

Streaming Delayed Price Updated: 10:06 AM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? ↗

September 05, 2025

It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.

Via Investor's Business Daily

Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speed ↗

September 05, 2025

Secretary for Health and Human Services, Robert F. Kennedy Jr., faced bipartisan backlash during a combative Senate hearing on Thursday, as both Republicans and Democrats criticized his controversial...

Via Benzinga

Topics Government

Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda ↗

September 04, 2025

Via Stocktwits

Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements ↗

September 04, 2025

California, Oregon and Washington form regional vaccine alliance to counter federal guidance under Robert F. Kennedy Jr. as Florida eliminates state mandates.

Via Benzinga

Novavax CFO Says Sanofi To Cover Majority Of Future Nuvaxovid Study Costs, Retail Urges Partnership Diversification ↗

August 06, 2025

Via Stocktwits

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Novavax Announces Positive Preclinical Data From Bird Flu Vaccine: Retail Wonders When Will The Stock Be Fairly Valued ↗

July 24, 2025

Via Stocktwits

Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' ↗

September 04, 2025

Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public...

Via Benzinga

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works ↗

September 01, 2025

Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.

Via Benzinga

Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens ↗

August 30, 2025

Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.

Via Benzinga

Elizabeth Warren Slams Trump's CDC Purge: Calls Out RFK Jr's Statements On Measles Vaccines — 'These Fools Can't Be Trusted With Your Health' ↗

August 29, 2025

Sen. Elizabeth Warren (D-Mass.) is sounding the alarm on President Donald Trump's attempts at overhauling leadership at the Centers for Disease Control and Prevention, warning of risks to public...

Via Benzinga

Topics Government

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines ↗

August 27, 2025

FDA approves Pfizer, Moderna, and Novavax Covid vaccines for high-risk groups as emergency authorizations end and vaccines transition to full marketing.

Via Benzinga

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. ↗

August 27, 2025

Shares of one vaccine-maker are under pressure on Robert F. Kennedy Jr.'s move on Wednesday.

Via Investor's Business Daily

Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups ↗

August 27, 2025

Moderna’s Covid vaccine has been authorized for individuals six months and older, Pfizer's for ages five and up, and Novavax's for ages 12 and above.

Via Stocktwits

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' ↗

August 25, 2025

The Trump administration may remove COVID-19 vaccines from the U.S. market as RFK Jr.'s allies gain influence at HHS, with a new vaccine task force led by a known skeptic.

Via Benzinga

Topics Government

Novavax Stock Suffers Sharpest Drop In Months After $225M Debt Deal; Retail Still Leans Bullish ↗

August 22, 2025

Bank of America’s downgrade to ‘Underperform’ with a $7 target deepened concerns over Sanofi’s limited commercialization of Nuvaxovid and higher hurdles for future partnerships.

Via Stocktwits

Novavax Shares Are Trading Higher Thursday: What's Going On? ↗

August 21, 2025

Via Benzinga

La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 20, 2025

Via Benzinga

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency ↗

August 12, 2025

CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.

Via Benzinga

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply ↗

August 11, 2025

Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern on board to fill in gaps.

Via Benzinga

Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction ↗

August 11, 2025

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.

Via Benzinga

Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk ↗

August 11, 2025

Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.

Via Benzinga

Novavax (NVAX) Profit Jumps on Milestone ↗

August 06, 2025

Via The Motley Fool

Upcoming Earnings Calls This Week: August 4th - August 10th, 2025

August 07, 2025

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...

Via MarketMinute

Topics Artificial Intelligence Economy

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales ↗

August 06, 2025

Novavax beats Q2 expectations with $239 million in revenue, lifts 2025 guidance, and reports profit as costs decline and commercial rights shift to Sanofi.

Via Benzinga

NOVAVAX INC (NASDAQ:NVAX) Surges on Q2 2025 Earnings Beat and FDA Approval for Nuvaxovid ↗

August 06, 2025

Novavax (NVAX) stock surges 5.5% pre-market after Q2 2025 earnings crush estimates with $239M revenue and $0.62 EPS, fueled by Sanofi deal and FDA approval for Nuvaxovid.

Via Chartmill

Topics Earnings

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies' ↗

August 06, 2025

The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million.

Via Benzinga

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector ↗

August 01, 2025

Shares of Novavax are trading lower Friday morning. The stock appears to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna reported disappointing Q2 results.

Via Benzinga

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates ↗

July 24, 2025

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose preclinical studies.

Via Benzinga

2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet ↗

July 11, 2025

Via The Motley Fool

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.